NCT03625362

Brief Summary

This study evaluates how 4-week supplementation with hydrogen-rich water affects liver fat accumulation, blood lipid profiles and body composition in patients with non-alcoholic fatty liver disease

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 10, 2018

Completed
22 days until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

April 16, 2019

Status Verified

April 1, 2019

Enrollment Period

4 months

First QC Date

August 6, 2018

Last Update Submit

April 15, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Liver fat content

    MRS spectra for liver triglycerides

    Change from baseline liver triglycerides at 4 weeks

Secondary Outcomes (2)

  • Total cholesterol

    Change from baseline total cholesterol at 4 weeks

  • Total body fatness

    Change from baseline fat percentage at 4 weeks

Study Arms (2)

Hydrogen

EXPERIMENTAL

1 L of hydrogen-rich water

Dietary Supplement: Hydrogen

Placebo

PLACEBO COMPARATOR

1 L of tap water

Dietary Supplement: Placebo

Interventions

HydrogenDIETARY_SUPPLEMENT

Hydrogen-rich water

Hydrogen
PlaceboDIETARY_SUPPLEMENT

Tap water

Placebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Body mass index \> 25 kg/m2
  • Free of major diseases besides NAFLD
  • Must be able to give written informed consent

You may not qualify if:

  • Use of any dietary supplements within 4 weeks before study commences
  • Abnormal values for lab clinical chemistry (\> 2 SD)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Applied Bioenergetics Lab at Faculty of Sport and PE

Novi Sad, Vojvodina, 21000, Serbia

Location

FSPE Applied Bioenergetics Lab

Novi Sad, Vojvodina, 21000, Serbia

Location

Related Publications (4)

  • Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res. 2008 Mar;28(3):137-43. doi: 10.1016/j.nutres.2008.01.008.

    PMID: 19083400BACKGROUND
  • Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N. Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr. 2010 Mar;46(2):140-9. doi: 10.3164/jcbn.09-100. Epub 2010 Feb 24.

    PMID: 20216947BACKGROUND
  • Korovljev D, Trivic T, Drid P, Ostojic SM. Molecular hydrogen affects body composition, metabolic profiles, and mitochondrial function in middle-aged overweight women. Ir J Med Sci. 2018 Feb;187(1):85-89. doi: 10.1007/s11845-017-1638-4. Epub 2017 May 30.

    PMID: 28560519BACKGROUND
  • Korovljev D, Stajer V, Ostojic J, LeBaron TW, Ostojic SM. Hydrogen-rich water reduces liver fat accumulation and improves liver enzyme profiles in patients with non-alcoholic fatty liver disease: a randomized controlled pilot trial. Clin Res Hepatol Gastroenterol. 2019 Nov;43(6):688-693. doi: 10.1016/j.clinre.2019.03.008. Epub 2019 Apr 11.

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

Hydrogen

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

ElementsInorganic ChemicalsGases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2018

First Posted

August 10, 2018

Study Start

September 1, 2018

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

April 16, 2019

Record last verified: 2019-04

Locations